GGHSX
Price
$44.14
Change
-$0.22 (-0.50%)
Updated
Sep 20 closing price
VGHCX
Price
$231.50
Change
-$1.77 (-0.76%)
Updated
Sep 20 closing price
Ad is loading...

GGHSX vs VGHCX

Header iconGGHSX vs VGHCX Comparison
Open Charts GGHSX vs VGHCXBanner chart's image
Invesco Health Care R6
Price$44.14
Change-$0.22 (-0.50%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$231.50
Change-$1.77 (-0.76%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GGHSX vs VGHCX Comparison Chart
Loading...
VS
GGHSX vs. VGHCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGHSX is a Buy and VGHCX is a Buy.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 51.1B vs. GGHSX (1.42B). VGHCX pays higher dividends than GGHSX: VGHCX (0.79) vs GGHSX (0.00). GGHSX was incepted earlier than VGHCX: GGHSX (7 years) vs VGHCX (40 years). GGHSX is a more actively managed with annual turnover of: 59.00 vs. VGHCX (16.00). VGHCX has a lower initial minimum investment than GGHSX: VGHCX (3000) vs GGHSX (1000000). GGHSX annual gain was more profitable for investors over the last year : 24.65 vs. VGHCX (12.51). VGHCX return over 5 years is better than : 17.75 vs. GGHSX (14.72).
GGHSXVGHCXGGHSX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years40 years-
Gain YTD17.76910.707166%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B51.1B3%
Annual Yield % from dividends0.000.79-
Returns for 1 year24.6512.51197%
Returns for 3 years-13.57-2.44555%
Returns for 5 years14.7217.7583%
Returns for 10 yearsN/A8.99-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDG9.460.29
+3.16%
Bridge Investment Group Holdings
NGD3.110.06
+1.97%
New Gold
LUMO3.930.01
+0.26%
Lumos Pharma
DNLI30.92-0.13
-0.42%
Denali Therapeutics
CVE17.11-0.11
-0.64%
Cenovus Energy